No taxation without representation.

Across all studies that resulted in FDA cancer drug approval from 2014-2018 (n=75), how many enrolled Black patients at a rate that at least reached the proportion of Black patients in the actual disease population? Zero. This editorial dives into the reasons why and ways we can address it. For example, lack of awareness and access can be ameliorated by educational efforts, strategic expansions of participating sites, and mandated minimums to receive continued funding. | Awidi, JCO Oncol Pract 2021